Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Studies show these help stimulate the secretion of GLP-1
Clinical studies have demonstrated that GLP-1 receptor agonists can reduce various inflammatory biomarkers , including: C-reactive protein (CRP) : A general marker of systemic inflammation Interleukin-6 (IL-6) : A pro-inflammatory cytokine Tumour necrosis factor-alpha (TNF-) : Another key inflammatory mediator Plasminogen activator inhibitor-1 (PAI-1) : Associated with cardiovascular inflammation The magnitude of these effects varies between studies and may depend on baseline inflammatory status, degree of weight loss achieved, and individual patient characteristics
Retatrutide is an investigational triple agonist (GIP, GLP-1, and glucagon receptor) not yet approved by the MHRA or EMA, and should only be used within regulated clinical trials or authorised supply channels
They work by: Regulating blood sugar levels Slowing gastric emptying (helping you feel full longer) Reducing appetite These effects can be incredibly beneficialbut they also introduce important considerations for women who are trying to conceive
Freeman and Company, 2017
US$ 21.26
US$ 27.97
US$ 27.85
US$ 23.61
US$ 26.09
US$ 20.27
US$ 28.73
